Lapatinib Tablet

Get a Price/Quote

MOQ : 50 Boxes

Lapatinib Tablet Specification

Salt Composition
Lapatinib

Indication
Breast cancer (HER2-positive), advanced or metastatic breast cancer

Dosage Form
Tablet

Enzyme Types
Not an enzyme-based drug

Feature
Oral administration, targeted therapy

Ingredients
Lapatinib, excipients (as per manufacturer)

Application
Oncology

Physical Color/Texture
Yellow colored film-coated tablet

Fermentation Smell
Odorless (pharmaceutical tablet)

Shelf Life
2 years from date of manufacture

Lapatinib Tablet Trade Information

Minimum Order Quantity
50 Boxes

FOB Port
Mundra Port

Supply Ability
1000 Boxes Per Month

Delivery Time
30 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Domestic Market
All India

Certifications
ISO, GMP, WHO

About Lapatinib Tablet

Product Details:

Minimum Order Quantity	50 Box
Dose	250 mg
Packaging Size	100 Tablets
Packaging Type	Box
Usage	Commercial, Clinical, Hospital, Personal

We are leading Exporter and Manufacturer of Lapatinib Tablet.

Uses
Lapatinib is used in the treatment of breast cancer.

How it works

Lapatinib In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Lapatinib blocks this signal, and thus stops the production of these cancer cells.

Common side effects
Nausea, Headache, Back pain, Breathing difficulty, Rash, Joint pain, Pain in extremity, Insomnia, Vomiting, Abdominal pain, Loss of appetite, Dyspepsia, Hot flushes, Diarrhoea, Cough, Nose bleed, Constipation, Stomatitis

Lapatinib Tablets exporter, Lapatinib Tablets manufacturer

Targeted Treatment for Advanced Breast Cancer

Lapatinib tablets are a leading choice in targeted therapy for HER2-positive, advanced or metastatic breast cancer. As a tyrosine kinase inhibitor, it blocks specific protein receptors involved in cancer cell growth. This precise mechanism benefits patients by potentially improving outcomes and reducing unwanted damage to healthy cells.

Convenient Oral Administration

The easy-to-use film-coated tablets allow for oral administration, offering patients the flexibility to take their medication at home. This reduces the need for frequent hospital visits and increases adherence to prescribed treatment regimens, supporting continuous cancer care.

Reliable Quality and Packaging

Supplied in blister strips within protective boxes, Lapatinib tablets maintain their quality throughout shelf life. Manufactured to pharmaceutical standards in India, the product ensures stability, potency, and safety when stored below 25C, as recommended.

FAQs of Lapatinib Tablet:

Q: How should Lapatinib Tablets be taken for breast cancer treatment?

A: Lapatinib Tablets should be taken orally as directed by a healthcare professional. It is typically prescribed as part of a regimen for HER2-positive advanced or metastatic breast cancer. Follow your doctors instructions carefully, swallowing the tablet whole with water.

Q: What precautions should be considered before starting Lapatinib?

A: Before starting Lapatinib, inform your doctor about any allergies, especially if you have known hypersensitivity to Lapatinib or its excipients. It is not recommended for use during pregnancy and may interact with CYP3A4 substrates or inhibitors, so discuss all current medications.

Q: When is Lapatinib contraindicated?

A: Lapatinib is contraindicated in individuals with a history of hypersensitivity to Lapatinib or any of its excipients. Always consult your healthcare provider about your medical history before initiating therapy.

Q: Where should Lapatinib Tablets be stored?

A: Lapatinib Tablets should be stored in a cool place below 25C, away from moisture and direct sunlight. Keep them in their original blister strip packaging within the box to protect their integrity.

Q: What are the key benefits of using Lapatinib Tablets?

A: Lapatinib offers the benefit of targeted therapy for HER2-positive breast cancer, aiming to impede cancer cell growth while sparing healthy tissue. Its oral form enhances patient convenience and adherence to treatment.

Q: Are there any common drug interactions associated with Lapatinib?

A: Yes, Lapatinib may interact with drugs metabolized by the CYP3A4 enzyme, including certain substrates and inhibitors. Inform your healthcare provider of all medications and supplements you are taking to avoid adverse interactions.

Q: How long does Lapatinib remain effective and usable from the date of manufacture?

A: Lapatinib Tablets have a shelf life of two years from the date of manufacture, provided they are stored appropriately as per the manufacturers guidelines.

Tell us about your requirement